ArticleNeurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology2026
Genotype-driven cerebrovascular risk across age and sex in hereditary hemorrhagic telangiectasia.
Article in Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
13 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundHereditary hemorrhagic telangiectasia (HHT) is a rare autosomal dominant vascular disorder characterized by multisystem arteriovenous malformations (AVMs). Still, the influence of demographic factors and specific pathogenic variants on systemic and cerebrovascular involvement remains incompletely defined.
methodsWe retrospectively included 142 patients with genetically confirmed HHT diagnosis. Systemic and neurovascular data were collected for each patient and stratified by age and sex. Then, we conducted univariate analyses for genotype-phenotype correlations after adjusting for age and sex. Afterwards, the significant associations were tested in multivariable logistic regression models to verify confounding effects.
resultsHepatic AVMs and gastrointestinal bleeding increased significantly with age, whereas neurological manifestations showed no age dependency. In multivariable analysis for hepatic AVMs, increasing age was independently associated with hepatic involvement (p = 0.037), while ENG (p = 0.035) was associated with a lower likelihood of hepatic AVMs compared to ACVRL1. For brain AVMs, age, ENG gene, and variant truncation status were independent predictors, and the ACVRL1 c.277 C > T (p.Arg93*) mutation showed an independent association (p = 0.035).
conclusionsIn HHT, age and gene-level effects are robust predictors of systemic AVM involvement, whereas mutation-specific associations remain difficult to evaluate. Larger multicenter studies are needed to validate variant-level risk and support personalized surveillance strategies.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.